Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Feb;1462(1):5-13.
doi: 10.1111/nyas.14274. Epub 2019 Dec 2.

Leveraging insights into cancer metabolism-a symposium report

Affiliations
Review

Leveraging insights into cancer metabolism-a symposium report

Jennifer Cable et al. Ann N Y Acad Sci. 2020 Feb.

Abstract

Tumor cells have devised unique metabolic strategies to garner enough nutrients to sustain continuous growth and cell division. Oncogenic mutations may alter metabolic pathways to unlock new sources of energy, and cells take the advantage of various scavenging pathways to ingest material from their environment. These changes in metabolism result in a metabolic profile that, in addition to providing the building blocks for macromolecules, can also influence cell signaling pathways to promote tumor initiation and progression. Understanding what pathways tumor cells use to synthesize the materials necessary to support metabolic growth can pave the way for new cancer therapeutics. Potential strategies include depriving tumors of the materials needed to grow or targeting pathways involved in dependencies that arise by virtue of their altered metabolis.

Keywords: cancer; cell signaling; ferroptosis; metabolism; micropinocytosis.

PubMed Disclaimer

Conflict of interest statement

Competing interests

The authors declare no competing interests. B.R.S. is an inventor on patents and patent applications related to ferroptosis, and holds equity in and serves as a consultant to Inzen Therapeutics.

References

    1. Nagarajan A, Malvi P & Wajapeyee N. 2016. Oncogene-directed alterations in cancer cell metabolism. Trends Cancer 2: 365–377. - PMC - PubMed
    1. Kalyanaraman B 2017. Teaching the basics of cancer metabolism: developing antitumor strategies by exploiting the differences between normal and cancer cell metabolism. Redox Biol. 12: 833–842. - PMC - PubMed
    1. Siemann DW 2011. The unique characteristics of tumor vasculature and preclinical evidence for its selective disruption by tumor-vascular disrupting agents. Cancer Treat. Rev 37: 63–74. - PMC - PubMed
    1. Selwan EM, Finicle BT, Kim SM, et al. 2016. Attacking the supply wagons to starve cancer cells to death. FEBS Lett. 590: 885–907. - PMC - PubMed
    1. Yang H, Ye D, Guan K-L, et al. 2012. IDH1 and IDH2 mutations in tumorigenesis: mechanistic insights and clinical perspectives. Clin. Cancer Res 18: 5562–5571. - PMC - PubMed